Archive for the ‘harvard’ Category
Harvard student publication retracts article saying Jews deserve punishment because “they killed Jesus”
(We’ll do a few conflict of interest disclosures, if just for the hell — oops — of it: Harvard is Ivan’s alma mater, and both of us are well, Jews. We note, however, that the Ichthus was not around in Ivan’s Harvard days, and neither of us was around when the events involving Jesus described in this post occurred.)
Martin Biosse-Duplan, a former Harvard dental school research fellow found by the Office of Research Integrity to have falsified results has had the two papers in question retracted.
Last week was a busy one at the U.S. Office of Research Integrity (ORI), at least judging by how many cases they posted. There were sanctions against researchers at Ohio State, Texas Tech, and the Gladstone Institutes, as we reported. And it turns out there was another case closed, of a former Harvard dental school research fellow, The Scientist reports.
According to the ORI, Martin Biosse-Duplan “engaged in research misconduct in research supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), grant R01 AR054450.”
The misconduct involved a lab presentation and two published abstracts: Read the rest of this entry »
In August of last year, Mladen Pavičić, chair of physics at the University of Zagreb’s Faculty of Civil Engineering, published a paper in Physical Review Letters on quantum teleportation, “Near-Deterministic Discrimination of All Bell States with Linear Optics.”
Just six days later, after hearing from a physicist in China, Pavičić — who is also affiliated with Harvard’s physics department — submitted a correction, which ran on the journal’s site in November. The correction begins: Read the rest of this entry »
The work of Sam W. Lee, a cancer biologist at Harvard and Massachusetts General Hospital, has come under fire at Science Fraud lately over concerns about the possible reuse of images in his group’s published studies.
Turns out there’s some there, there after all. The journal Current Biology has issued a pretty thorny correction for one of Lee’s 2006 articles, “RhoE Is a Pro-Survival p53 Target Gene that Inhibits ROCK I-Mediated Apoptosis in Response to Genotoxic Stress,” citing multiple issues with its figures: Read the rest of this entry »
JAMA has issued its first-ever Expression of Concern over a 2007 study of hip protectors in the elderly that came under scrutiny from Federal regulators.
Two years after questions surfaced about work by former Harvard psychology professor Marc Hauser, an official government report is finally out.
It’s not pretty.
The findings by the Office of Research Integrity were first reported by the Boston Globe, which was also first to report the issues in Hauser’s work. They’re extensive, covering misconduct in four different NIH grants (we’ve added some links for context): Read the rest of this entry »
Shane Mayack, a former post-doc in Harvard lab of Amy Wagers, a rising star in the stem cell field, has been sanctioned by the Office of Research Integrity for misconduct.
Mayack, who has defended her actions on this blog as honest error — albeit sloppiness — and has not admitted to wrongdoing, must undergo supervision if she receives any federal grant funding over the next three years, under the voluntary agreement.
Alzheimer’s & Dementia has retracted a meeting abstract the journal published without the OK of the researchers, a top group from Harvard, who submitted it but withdrew the work before the conference.
That, as they say, might require some unpacking. Maybe this will make things clearer.
Raj Hooli, a graduate student in the lab of Rudolph Tanzi, a leading neuroscientist at Harvard — where he holds the Joseph P. and Rose F. Kennedy endowed chair of neurology — had submitted the abstract, “Genome-wide assessment of copy number variations in early-onset Alzheimer’s disease,” for consideration at the International Conference on Alzheimer’s Disease (ICAD).
As Tanzi explains: Read the rest of this entry »